These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis. Hartzell JD; Aronson NE; Nagaraja S; Whitman T; Hawkes CA; Wortmann G Am J Trop Med Hyg; 2006 Apr; 74(4):591-2. PubMed ID: 16606989 [TBL] [Abstract][Full Text] [Related]
3. Varicella zoster virus--specific immune response after treatment with sodium stibogluconate for cutaneous leishmaniasis. Yoon IK; Cox J; Zhou Y; Lukes Y; Reinhardt B; Valencia-Micolta A; Wortmann G Am J Trop Med Hyg; 2008 Mar; 78(3):402-5. PubMed ID: 18337334 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Wortmann G; Miller RS; Oster C; Jackson J; Aronson N Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091 [TBL] [Abstract][Full Text] [Related]
5. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis. Hartzell JD; Aronson N N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214 [No Abstract] [Full Text] [Related]
6. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis. Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787 [TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous leishmaniasis patients with pentostam via intralesion infiltration. Nagaty IM; Lashin AH J Egypt Soc Parasitol; 2000 Apr; 30(1):177-82. PubMed ID: 10786029 [TBL] [Abstract][Full Text] [Related]
9. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486 [TBL] [Abstract][Full Text] [Related]
10. Experience with New World cutaneous leishmaniasis in travelers. Scope A; Trau H; Anders G; Barzilai A; Confino Y; Schwartz E J Am Acad Dermatol; 2003 Oct; 49(4):672-8. PubMed ID: 14512915 [TBL] [Abstract][Full Text] [Related]
11. Clinical exacerbation developing during treatment of cutaneous leishmaniasis: an id reaction? Yeşilova Y; Özbilgin A; Turan E; Altın Sürücü H; Aksoy M Turkiye Parazitol Derg; 2014 Dec; 38(4):281-2. PubMed ID: 25732891 [No Abstract] [Full Text] [Related]
12. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Aronson NE; Wortmann GW; Johnson SC; Jackson JE; Gasser RA; Magill AJ; Endy TP; Coyne PE; Grogl M; Benson PM; Beard JS; Tally JD; Gambel JM; Kreutzer RD; Oster CN Clin Infect Dis; 1998 Dec; 27(6):1457-64. PubMed ID: 9868660 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis. Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663 [TBL] [Abstract][Full Text] [Related]
15. [Cutaneous leishmaniasis and multidermatomic herpes zoster]. Arboleda M; Jaramillo L; Ortiz D; Díaz A Rev Chilena Infectol; 2013 Dec; 30(6):680-2. PubMed ID: 24522317 [TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani. Ranawaka RR; Weerakoon HS J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389 [TBL] [Abstract][Full Text] [Related]
17. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Hepburn NC; Tidman MJ; Hunter JA Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779 [TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of sodium stibogluconate in leishmaniasis. Hepburn NC; Siddique I; Howie AF; Beckett GJ; Hayes PC Lancet; 1993 Jul; 342(8865):238-9. PubMed ID: 8100955 [No Abstract] [Full Text] [Related]
19. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Herwaldt BL; Berman JD Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity]. Saldanha AC; Romero GA; Guerra C; Merchan-Hamann E; Macedo Vde O Rev Soc Bras Med Trop; 2000; 33(4):383-8. PubMed ID: 10936953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]